ArticleNPJ digital medicine2026
Mapping the role of artificial intelligence in health-related stigma: a scoping review.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Stigma remains a major barrier to equitable health and well-being, while artificial intelligence (AI) is increasingly recognized as a tool with both potential and risk in addressing this challenge. However, research on AI and stigma is fragmented across disciplines, hindering a unified understanding of their intersection. To consolidate existing evidence, we conducted a scoping review of 11,769 records published between 2016 and 2025 and identified 70 studies examining the relationship between AI and health-related stigma. Four research themes emerged: AI measuring stigma (n = 42, 60%), stigma influencing AI use (n = 15, 21%), AI increasing stigma (n = 9, 13%), and AI reducing stigma (n = 4, 6%). Most studies focused on mental health disorders, revealing an imbalance in attention to other health conditions. Across studies, we observed inconsistent definitions of stigma, limited cross-cultural perspectives, and few evaluations of real-world AI applications. Addressing these gaps will be critical for developing responsible and equitable AI systems that mitigate rather than reinforce health stigma across broader societal and health contexts.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.